Feb 9, 2015 4 min

Pharmacogenomics

Dr Sebastian Nijman develops new approaches to study signalling networks in cancer cells and uncover specific weaknesses, particularly in breast and lung cancer. This can be used to develop more effective drugs and to better guide treatment decisions. In the context of cancer, genetic diversity means that we respond differently to various treatments. Pharmacogenomics sits at the intersection between genetics and drugs. Better understanding of the genetic landscape of cancer and the recent increase of targeted drugs allow us to better match patients with the best treatments, improving care.

Episode details come from the podcast's RSS feed.

Embed this episode

Attribution link and audio player

Ready to play

Pharmacogenomics

0:00 4:27

No transcript yet.

Requests help us decide what to transcribe next.

Share this episode

Similar podcasts

French Your Way Jessica: Native French teacher founder of French Your Way Boost your French listening skills and test your comprehension with this one of a kind series of podcasts. Get the chance to listen to a real conversation between native speakers talking at normal speed AND customise your learning experience through carefully designed sets of questions (2 levels of difficulty) available for download at www.frenchvoicespodcast.com. All interviews also come with the transcript. French teacher Jessica interviews native speakers of French from around the world who share a bit of their life and passion. Where else would you meet in one same place a French yoga teacher based in Melbourne, a soap manufacturer from Provence, or a couple cycling around the world?

Frequently asked questions

How long is this episode of Translational and Clinical?

This episode is 4 minutes long.

When was this Translational and Clinical episode published?

This episode was published on February 9, 2015.

Can I download this Translational and Clinical episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.